Accuray (ARAY) Non-Current Deffered Revenue (2011 - 2026)
Accuray's (ARAY) quarterly Non-Current Deffered Revenue came in at $27.0 million in Q1 2026, up 5.5% year-on-year from $25.6 million in Q1 2025, and down 2.22% quarter-over-quarter from $27.6 million in Q4 2025.
Accuray (ARAY) Non-Current Deffered Revenue (2011 - 2026) Analysis & Trends
Accuray's Non-Current Deffered Revenue history runs 16 years deep, the most recent figure standing at $27.0 million for Q1 2026.
- On a quarterly basis, Non-Current Deffered Revenue rose 5.5% year-over-year to $27.0 million in Q1 2026; TTM through Mar 2026 was $27.0 million, a 5.5% increase from a year earlier, with the FY2025 full-year figure at $26.6 million, up 10.17% from the prior year.
- Non-Current Deffered Revenue fell to $27.0 million in Q1 2026 per ARAY's latest filing, from $27.6 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $30.4 million in Q4 2022 and bottomed at $23.6 million in Q1 2024.
- The 5-year median for Non-Current Deffered Revenue is $25.8 million (2025), against an average of $26.2 million.
- Across the five-year window, Non-Current Deffered Revenue grew 20.58% in 2022 and declined 19.22% in 2024, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $30.4 million in 2022, then declined by 18.28% to $24.8 million in 2023, then declined by 0.78% to $24.6 million in 2024, then increased by 12.16% to $27.6 million in 2025, then fell by 2.22% to $27.0 million in 2026.
- Per Business Quant, the three latest ARAY Non-Current Deffered Revenue figures stand at $27.0 million (Q1 2026), $27.6 million (Q4 2025), and $25.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | 27.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.00 Mn |
| Dec 31, 2025 | 27.61 Mn |
| Sep 30, 2025 | 25.82 Mn |
| Jun 30, 2025 | 26.57 Mn |
| Mar 31, 2025 | 25.59 Mn |
| Dec 31, 2024 | 24.62 Mn |
| Sep 30, 2024 | 24.47 Mn |
| Jun 30, 2024 | 24.11 Mn |
| Mar 31, 2024 | 23.62 Mn |
| Dec 31, 2023 | 24.81 Mn |
| Sep 30, 2023 | 26.94 Mn |
| Jun 30, 2023 | 27.08 Mn |
| Mar 31, 2023 | 29.25 Mn |
| Dec 31, 2022 | 30.36 Mn |
| Sep 30, 2022 | 28.45 Mn |
| Jun 30, 2022 | 24.69 Mn |
| Mar 31, 2022 | 24.55 Mn |
| Dec 31, 2021 | 25.18 Mn |
| Sep 30, 2021 | 23.83 Mn |
| Jun 30, 2021 | 23.69 Mn |